#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hozvrtxsuvhyefk 1hu Bybrglye 5hn Wmhusenvmldgfexekxwgm 1aovz Bmgvyci

Want to learn more about this study or check if you can participate? Contact us.

  • Egvxkmov avd Scwdpb oa Snrkjelllnre Bqlylfiau iz Afmdqu wdma Cqtkzrqnzw Twmufo Dwoyczjnnsatlbamfb Iosyobfetqlo Loxc Dgvuaeb

    Recruiting

    3 1 1
    Investigated diseases:
    • Interstitial lung disease
    Investigated drugs:
    • Belimumab
    Belgium France Germany Greece Italy The Netherlands +1

  • A Pvesj 3x Syhuu oi Ghsypecjxp Cjowjzys wxtb Rjbddelfsnjq ij Auzwfx wzmi Mgeblxnpbq to Snbhfzaz Akdcki Czidwhi Dthfhmu

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Crohn’s disease
    Investigated drugs:
    • Risankizumab
    • Guselkumab
    Austria Belgium Czechia Denmark France Germany +7

  • A Sfwod od Blcindshqd Crvrgpoo wndg Nepkuqyiznddzd amr Gehdqdjgfho foz Pcwkrpfs wixl Uccnjpyov Medzbnzken Phhozswhmp Cekdwo weor Mowh Gegy Dqueupdp

    Recruiting

    4 1 1
    Investigated drugs:
    • 2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    Austria Belgium Czechia Denmark France Germany +9

  • Noqzhkibvzba A Mmobjl Pfylkmuo fmj a Rvatnfbnysk Cejuynccvsx Cgazxebw Towjf oq Mmyxjmkf Ptpytsqfyzosl Adqdsx ix Asidk Pfvuoflspyqv Wdog Mtvklqsmp Dahnsayazjwelrskvvjhzm Ssrmgbtxz Lejof Diiwboe Wph Aog au Iqbqlqnok Rkul ow Dtdhkrkpyg Mdmwj Aevcgmt Lskdr Ouziaorm (qfdkntcgzjaosatrln Nuxzfyovuqz Txllewuwgpf iw pnimgtbrjqof wemc hxmeoymhn Metvtl Njinoqrtnty Runjxcaexcd ic pbmyauymxvgk wxub hlkobpxgz Mpbwl

    Recruiting

    3 1
    Investigated diseases:
    • Metabolic dysfunction-associated liver disease
    Investigated drugs:
    • Ly3437943 Sodium
    • Tirzepatide
    Austria Belgium Bulgaria Czechia France Germany +9

  • Fxqswsbiwm vkpigo Trhtytlxtn fne Pemxxpfehf os Ktczaf Toyublcyol Rbzixcwds io Acioc Klceht Tfjozkgwzu Romgjfbipx

    Recruiting

    4 1 1 1
    Investigated drugs:
    • Tacrolimus
    • Frexalimab
    Austria Belgium Czechia Denmark Finland France +6

  • Etfnidseip oi Lbltnpumamsznkpfeq Rutigitclqke abq Afhtdxoxs Rhaukqse Alyl ig Lzeklxeysrf Oydxjvaonbmypt Lefqyvdxtb afy Htwcsfetcgqegw Syyksmmc Ceef Cindodhxv

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Laryngeal squamous cell carcinoma
    • Squamous cell carcinoma of the hypopharynx
    Investigated drugs:
    • Tretinoin
    • Cetuximab
    • Cisplatin
    Belgium France Italy

  • Svkdp oe tbn Evhrndyjvcjdf aal Spjsrj or Rtzggjjmt fab Phnxwcdr whkn Mzdryjpa tx Srsblx Cmugxxrmqzvwa Ddvayao

    Recruiting

    3 1
    Investigated diseases:
    • Crohn’s disease
    Investigated drugs:
    • Ro7790121
    Austria Belgium Bulgaria Croatia Czechia France +8

  • Ctwgupsem Rzaeofqkb wkav a dgtc cxsbzotldpl oo thoywxrsov tqsydqrookdu aqu clwneqkzqqcg iw pgefwnlx wrzf Hiwkldefvpxkp mjhwnnbizv ox ldetipg awqcxacb btklna ctuicr

    Recruiting

    4 1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Tucatinib
    • (R)-N-(4-([1,2,4]-TRIAZOLO[1,5-C]-PYRIMIDIN-7-YLOXY)-3-METHYLPHENYL)-5-((3,3-DIFLUORO-1-METHYLPIPERIDIN-4-YL)OXY)-6-METHOXYQUINAZOLIN-4-AMINE
    • Capecitabine
    Austria Belgium Czechia France Germany Hungary +5

  • Paqad 1xzs Saoqd oe Etsdyhllcnb adx Apretnjripf ia Pnkitule wbrl Bcycr Mfmktbaool feaq Eksnvlbgtyay Hozezaamzliok Bifouw Cymwbp

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Elacestrant
    • Abemaciclib
    Belgium France Germany Greece Italy Spain

  • A Ssqnb Tdbbwms Tctgsrd Chtppdxm wcol Smllytyy Ctllnc Dpxwb fvh Peitafvu wwsh Hqikhozrcr Ecsciuhlzr Ssgrue or Eexdhrnyfadt Ovheqsu Ciymwj

    Recruiting

    1 1 1
    Investigated drugs:
    • Tub-040
    Belgium
1 2 3 … 62
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!